Journal of the Advanced Practitioner in Oncology

Journal of the Advanced Practitioner in Oncology We are the first peer-reviewed journal developed for advanced practitioners in oncology.

The Journal of the Advanced Practitioner in Oncology (JADPRO) is a peer-reviewed publication published 8 times a year.

Advanced Practitioners, share your work with your peers by submitting an abstract to  ! Present innovative, original wor...
03/05/2026

Advanced Practitioners, share your work with your peers by submitting an abstract to ! Present innovative, original work that is significant to the role of the advanced practitioner in oncology and hematology.

Learn more about the poster tracks and access full guidelines: https://bit.ly/3OFOlbQ

JADPRO Clinical Case Series presents Targeted Therapy Management in HR+ Metastatic Breast Cancer.Read the case studies a...
03/03/2026

JADPRO Clinical Case Series presents Targeted Therapy Management in HR+ Metastatic Breast Cancer.
Read the case studies and watch the webinar led by Melissa Rikal, FNP-BC, AOCNP, of Sarah Cannon Research Institute to learn more about managing such complex practical situations.
Learn more: https://caseseries.advancedpractitioner.com/25breast/

Let the countdown begin! Open your calendar and block these dates for JADPRO Live 2026: October 15-18. We want you to se...
02/27/2026

Let the countdown begin! Open your calendar and block these dates for JADPRO Live 2026: October 15-18. We want you to see you there!
Stay connected to JADPROLive.com for more info. Registration opens in the Spring!

As cancer care demands grow, so does the need for skilled research leaders.This innovative educational program equips on...
02/25/2026

As cancer care demands grow, so does the need for skilled research leaders.
This innovative educational program equips oncology APs with the knowledge, mentorship, and confidence to serve as PIs—helping close a gap in AP clinical trial leadership.
Learn more: https://bit.ly/4rxKY4U

Managing Eye-Related Adverse Events Caused by Cancer Treatments Learn more: https://go.conexiant.com/Eye-RelatedIntended...
02/24/2026

Managing Eye-Related Adverse Events Caused by Cancer Treatments

Learn more: https://go.conexiant.com/Eye-Related

Intended for US Healthcare Professionals.
©2025 AstraZeneca. All rights reserved.
US-107229 Last Updated 12/25

ICYMI: The January/February issue of the Journal of the Advanced Practitioner in Oncology is LIVE! Discover ways to impr...
02/17/2026

ICYMI: The January/February issue of the Journal of the Advanced Practitioner in Oncology is LIVE!

Discover ways to improve the quality of care for patients with cancer, support critical issues in advanced practice in oncology and recognize the expanding contributions of advanced practitioners in oncology.

Highlights of this issue include:
- Use of Remote Monitoring in Care Management for Bone Marrow Transplant Patients
- Melatonin for the Management of Cancer-Related Fatigue in Breast Cancer
- Integrative Oncology Models of Care
- The first FDA-approved product for the management of congenital thrombotic thrombocytopenic purpura
And more!

Read the issue: https://jadpro.com/issues/volume-17-number-1-janfeb-2026/

In Grand Rounds, an unknown G6PD deficiency led to hemolytic anemia after an infusion of rasburicase. In Diagnostic Snapshot, a patient’s primary care physician previously noted low white blood cell count, and it was found that he had a benign hematology phenomenon known as benign ethnic neut...

Cancer-related fatigue remains one of the most challenging symptoms in breast cancer care.An integrative review suggests...
02/12/2026

Cancer-related fatigue remains one of the most challenging symptoms in breast cancer care.
An integrative review suggests melatonin may improve CRF, with studies showing benefit at 5 mg and 18 mg—particularly when physical activity isn’t feasible.
Read the review: https://bit.ly/4r9oirb

A routine intervention can become a medical emergency.This case report describes acute hemolysis following rasburicase i...
02/10/2026

A routine intervention can become a medical emergency.
This case report describes acute hemolysis following rasburicase infusion in a patient with previously unrecognized G6PD deficiency—a reminder of the importance of screening and medication awareness in oncology care.
Read the full case report: https://bit.ly/3M35b3g

In oncology, listening is a clinical skill.Narrative medicine offers advanced practitioners structured tools—attentive l...
02/06/2026

In oncology, listening is a clinical skill.
Narrative medicine offers advanced practitioners structured tools—attentive listening, reflective writing, and open-ended questioning—to better understand patients’ stories and strengthen therapeutic relationships.
Connection can be care.
Learn more in JADPRO: https://bit.ly/4r7P1V8

Planning is well under way for   2026 and this is always an exciting time as we work to put it all together for you. Wha...
02/04/2026

Planning is well under way for 2026 and this is always an exciting time as we work to put it all together for you. What are your ideas? Share them with us here or connect with us via JADPROLive.com

Address

94 N Woodhull Road
Huntington, NY
11743

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when Journal of the Advanced Practitioner in Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Journal of the Advanced Practitioner in Oncology:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

The Journal of the Advanced Practitioner in Oncology (JADPRO) is a peer-reviewed publication published 8 times a year.